Yang, Yuecheng
Zhang, Yunkui
Dai, Sheng Ling
Wang, Lu
Zhang, Jun
Funding for this research was provided by:
Shenkang Three-year Clinical Research Foundation (HDC2020CR3031B)
Article History
Received: 27 September 2022
Accepted: 14 December 2022
First Online: 19 December 2022
Declarations
:
: Our study was approved by the Ethics Committee of Shanghai Cancer Center (Ethics Approval Number: 1612167–18). The Ethics Committee of the Shanghai Cancer Center (Ethics Approval Number: 1612167–18) waived the requirement for informed consent. All methods were performed in accordance with the relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests. Funding: This work was supported by Shenkang Three-year Clinical Research Foundation (No.HDC2020CR3031B).